Literature DB >> 33375453

Evaluation of a Microhaplotype-Based Noninvasive Prenatal Test in Twin Gestations: Determination of Paternity, Zygosity, and Fetal Fraction.

Zhaochen Bai1,2, Hu Zhao1,2, Shaobin Lin3, Linhuan Huang3, Zhiming He3, Huan Wang4, Xueling Ou1,2.   

Abstract

As a novel type of genetic marker, the microhaplotype has shown promising potential in forensic research. In the present study, we analyzed maternal plasma cell-free DNA (cfDNA) samples from twin pregnancies to validate microhaplotype-based noninvasive prenatal testing (NIPT) for paternity, zygosity, and fetal fraction (FF). Paternity was determined with the combined use of the relMix package, zygosity was evaluated by examining the presence of informative loci with two fetal genome complements, and FF was assessed through fetal allele ratios. Paternity was determined in 19 twin cases, among which 13 cases were considered dizygotic (DZ) twins based on the presence of 3~10 informative loci and the remaining 6 cases were considered monozygotic (MZ) twins because no informative locus was observed. With the fetal genomic genotypes as a reference, the accuracy of paternity and zygosity determination were confirmed by standard short tandem repeat (STR) analysis. Moreover, the lower FF, higher FF, and combined FF in each DZ plasma sample were closely related to the estimated value. This present preliminary study proposes that microhaplotype-based NIPT is applicable for paternity, zygosity, and FF determination in twin pregnancies, which are expected to be advantageous for both forensic and clinical settings.

Entities:  

Keywords:  fetal fraction; microhaplotype; non-invasive prenatal testing; paternity; twins; zygosity

Mesh:

Year:  2020        PMID: 33375453      PMCID: PMC7823673          DOI: 10.3390/genes12010026

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  37 in total

1.  In-vitro fertilisation and risk of multiple pregnancy.

Authors:  Ruwan Wimalasundera; Nicholas M Fisk
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

2.  Facilitating complex DNA mixture interpretation by sequencing highly polymorphic haplotypes.

Authors:  Lev Voskoboinik; Uzi Motro; Ariel Darvasi
Journal:  Forensic Sci Int Genet       Date:  2018-05-02       Impact factor: 4.882

3.  Performance comparison of Illumina and ion torrent next-generation sequencing platforms for 16S rRNA-based bacterial community profiling.

Authors:  Stephen J Salipante; Toana Kawashima; Christopher Rosenthal; Daniel R Hoogestraat; Lisa A Cummings; Dhruba J Sengupta; Timothy T Harkins; Brad T Cookson; Noah G Hoffman
Journal:  Appl Environ Microbiol       Date:  2014-09-26       Impact factor: 4.792

4.  Noninvasive prenatal paternity testing by maternal plasma DNA sequencing in twin pregnancies.

Authors:  Yifan Xie; Ning Qu; Shaobin Lin; Haojun Jiang; Yanyan Zhang; Xiuqing Zhang; Hao Liang; Fang Chen; Xueling Ou
Journal:  Electrophoresis       Date:  2020-05-14       Impact factor: 3.535

5.  A sequence-based 74plex microhaplotype assay for analysis of forensic DNA mixtures.

Authors:  Fabio Oldoni; Drew Bader; Chiara Fantinato; Sharon C Wootton; Robert Lagacé; Kenneth K Kidd; Daniele Podini
Journal:  Forensic Sci Int Genet       Date:  2020-08-11       Impact factor: 4.882

6.  Development and comprehensive evaluation of a noninvasive prenatal paternity testing method through a scaled trial.

Authors:  Liao Chang; Huiyun Yu; Xinyao Miao; Jianbo Zhang; Shengbin Li
Journal:  Forensic Sci Int Genet       Date:  2019-08-29       Impact factor: 4.882

7.  Analysis of nondegraded and degraded DNA mixtures of close relatives using massively parallel sequencing.

Authors:  Hsiao-Lin Hwa; Ming-Yih Wu; James Chun-I Lee; Hsiang-I Yin; Pi-Mei Hsu; Shwu-Fang Li; Wuh-Liang Hwu; Chih-Wen Su
Journal:  Leg Med (Tokyo)       Date:  2019-10-25       Impact factor: 1.376

8.  Mixture deconvolution by massively parallel sequencing of microhaplotypes.

Authors:  Lindsay Bennett; Fabio Oldoni; Kelly Long; Selena Cisana; Katrina Madella; Sharon Wootton; Joseph Chang; Ryo Hasegawa; Robert Lagacé; Kenneth K Kidd; Daniele Podini
Journal:  Int J Legal Med       Date:  2019-02-13       Impact factor: 2.686

9.  Effective noninvasive zygosity determination by maternal plasma target region sequencing.

Authors:  Jing Zheng; Chenming Xu; Jing Guo; Yuan Wei; Huijuan Ge; Xuchao Li; Chunlei Zhang; Haojun Jiang; Ling Pan; Weiping Tang; Weiwei Xie; Hongyun Zhang; Yangyu Zhao; Fuman Jiang; Shengpei Chen; Wei Wang; Xun Xu; Fang Chen; Hefeng Huang; Hui Jiang
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

10.  Noninvasive prenatal paternity testing by means of SNP-based targeted sequencing.

Authors:  Jacqueline Chor Wing Tam; Yee Man Chan; Shui Ying Tsang; Chung In Yau; Shuk Ying Yeung; Ka Ki Au; Chun Kin Chow
Journal:  Prenat Diagn       Date:  2020-02-20       Impact factor: 3.050

View more
  4 in total

1.  Noninvasive Prenatal Paternity Testing with a Combination of Well-Established SNP and STR Markers Using Massively Parallel Sequencing.

Authors:  Xuefeng Shen; Ran Li; Haixia Li; Yu Gao; Hui Chen; Ning Qu; Dan Peng; Riga Wu; Hongyu Sun
Journal:  Genes (Basel)       Date:  2021-03-22       Impact factor: 4.096

Review 2.  Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review.

Authors:  Cechuan Deng; Shanling Liu
Journal:  Front Pediatr       Date:  2022-01-27       Impact factor: 3.418

3.  Set of 15 SNP-SNP Markers for Detection of Unbalanced Degraded DNA Mixtures and Noninvasive Prenatal Paternity Testing.

Authors:  Rangran Zhang; Yu Tan; Li Wang; Hui Jian; Jing Zhu; Yuanyuan Xiao; Mengyu Tan; Jiaming Xue; Fan Yang; Weibo Liang
Journal:  Front Genet       Date:  2022-02-10       Impact factor: 4.599

4.  Applications of massively parallel sequencing in forensic genetics.

Authors:  Thássia Mayra Telles Carratto; Vitor Matheus Soares Moraes; Tamara Soledad Frontanilla Recalde; Maria Luiza Guimarães de Oliveira; Celso Teixeira Mendes-Junior
Journal:  Genet Mol Biol       Date:  2022-09-19       Impact factor: 2.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.